{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:23:11Z","timestamp":1791174191339,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.nucmedbio.2007.01.009","type":"journal-article","created":{"date-parts":[[2007,3,31]],"date-time":"2007-03-31T11:19:45Z","timestamp":1175339985000},"page":"405-413","source":"Crossref","is-referenced-by-count":14,"title":["Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects"],"prefix":"10.1016","volume":"34","author":[{"given":"Roger E.","family":"McLendon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Akabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry S.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Cleveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkcan","family":"Cokgor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"James E.","family":"Herndon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Wikstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan T.","family":"Boulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darell D.","family":"Bigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Zalutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.nucmedbio.2007.01.009_bib1","first-page":"151S","article-title":"Current status of therapy of solid tumors: brain tumor therapy","volume":"46","author":"Zalutsky","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib2","series-title":"Radiation injury to the central nervous system","first-page":"191","article-title":"The pathology of central nervous system radiation injury","author":"Burger","year":"1991"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib3","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/1097-0142(197910)44:4<1256::AID-CNCR2820440415>3.0.CO;2-T","article-title":"The morphologic effects of radiation administered therapeutically for intracranial gliomas: a postmortem study of 25 cases","volume":"44","author":"Burger","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0360-3016(81)90130-9","article-title":"Soft-tissue reactions following irradiation of primary brain and pituitary tumors","volume":"7","author":"Baglan","year":"1981","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000411642","article-title":"The risk of cerebral radionecrosis in relation to dose, time and fractionation. A follow-up study","volume":"29","author":"Marks","year":"1985","journal-title":"Prog Exp Tumor Res"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1042-3680(18)30691-0","article-title":"The role of radiosurgery in the treatment of malignant brain tumors","volume":"3","author":"Coffey","year":"1992","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib7","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/jnci\/82.24.1918","article-title":"Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma","volume":"82","author":"Loeffler","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-642-85039-4_12","article-title":"Interstitial brachytherapy of malignant gliomas: the Memorial Sloan-Kettering Cancer Center experience","volume":"13","author":"Malkin","year":"1994","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib9","first-page":"631","article-title":"Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors","volume":"40","author":"Akabani","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0360-3016(99)00500-3","article-title":"Dosimetry and dose\u2013response relationships in newly diagnosed patients with malignant gliomas treated with iodine-131-labeled anti-tenascin monoclonal antibody 81C6 therapy","volume":"46","author":"Akabani","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib11","first-page":"2796","article-title":"Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody","volume":"43","author":"Bourdon","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jcb.240280302","article-title":"Immunochemical and biochemical characterization of a glioma-associated extracellular matrix glycoprotein","volume":"28","author":"Bourdon","year":"1985","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-5728(92)90029-K","article-title":"Tenascin expression in human glioma cell lines and normal tissues","volume":"36","author":"Ventimiglia","year":"1992","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib14","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1200\/JCO.1998.16.6.2202","article-title":"Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results","volume":"16","author":"Bigner","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00000478-199205000-00008","article-title":"Macrophage markers in diagnostic neuropathology","volume":"16","author":"Hulette","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/jcp.41.9.963","article-title":"Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen","volume":"41","author":"Brandtzaeg","year":"1988","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib17","series-title":"Russell and Rubinstein's pathology of tumors of the nervous system","first-page":"251","author":"Wikstrand","year":"1998"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3171\/jns.1995.82.3.0436","article-title":"Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?","volume":"82","author":"Forsyth","year":"1995","journal-title":"J Neurosurg"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib19","series-title":"Handbook of nuclear chemistry, Volume 4: Radiochemistry and radiopharmaceutical chemistry in life sciences","first-page":"315","article-title":"Radionuclide therapy","author":"Zalutsky","year":"2003"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib20","first-page":"1376","article-title":"Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors","volume":"39","author":"Marriott","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/bjc.1993.25","article-title":"Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry","volume":"67","author":"Papanastassiou","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-642-79952-5_11","article-title":"The treatment of patients with recurrent malignant gliomas with intratumoral radioimmunoconjugates","volume":"141","author":"Hopkins","year":"1996","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijc.2910510103","article-title":"Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I-labelled anti-tenascin monoclonal antibody BC-2","volume":"51","author":"Riva","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib24","first-page":"3275s","article-title":"Loco-regional radioimmunotherapy of high-grade malignant gliomas using specific monoclonal antibodies labeled with 90Y: a phase I study","volume":"5","author":"Riva","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib25","first-page":"79","article-title":"Experimental MR study of cerebral radiation injury: quantitative T2 changes over time and histopathologic correlation","volume":"16","author":"Miot","year":"1995","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3171\/jns.1990.73.4.0585","article-title":"Brain damage from 125I brachytherapy evaluated by MR imaging, a blood\u2013brain barrier tracer, and light and electron microscopy in a rat model","volume":"73","author":"Bernstein","year":"1990","journal-title":"J Neurosurg"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/1097-0142(197808)42:2<717::AID-CNCR2820420244>3.0.CO;2-3","article-title":"The central nervous system in childhood leukemia: III. Mineralizing microangiopathy and dystrophic mineralization","volume":"42","author":"Price","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2176\/nmc.32.739","article-title":"Preliminary results of interstitial 192Ir brachytherapy for malignant gliomas","volume":"32","author":"Matsumoto","year":"1992","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.nucmedbio.2007.01.009_bib29","series-title":"Radiation pathology","first-page":"351","author":"Fajardo","year":"2001"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805107000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805107000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T23:22:38Z","timestamp":1556320958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805107000364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0969805107000364"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2007.01.009","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}